Phase II Early Behavioral Intervention in BMT w/ Sleep Disturbance-Assess QOL+Fatigue+Cognitive f(x)

Not Recruiting

Trial ID: NCT01536977


This pilot clinical trial studies early brief behavioral intervention in treating sleep disturbance and improving quality of life in patients undergoing bone marrow transplant (BMT). A brief behavioral intervention may reduce symptoms of insomnia and fatigue and improve quality of life and cognitive function in patients undergoing BMT

Official Title

Early Behavioral Intervention in BMT Recipients With Sleep Disturbance: Assessing Its Impact on Quality of Life, Fatigue and Cognitive Function

Stanford Investigator(s)

Laura Johnston
Laura Johnston

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)


Patients proceeding to BMT within the Stanford Adult BMT program will be screened for

Inclusion Criteria:

   - Patient is scheduled to receive bone marrow transplantation.

   - Patient has a diagnosis of Non-Hodgkin's Lymphoma

   - Patient is at least 21 years old

   - Patient is able to understand written and spoken English

   - has preferred sleep phase between 9:00 pm and 3:00 am and a habitual rise time between
   4:00 am and 11:00 am

   - Patient receives a score of 8 or more on the Insomnia Severity Index or takes sleep
   medications 3 times a week

Exclusion criteria:

   - Has an unstable medical or psychiatric illness (Axis I - current or within the last 5

   - Existing cognitive disability

   - Is currently pregnant or nursing

   - Has a history of substance abuse or meets criteria for current alcohol abuse or

   - Has a self-reported history of chronic pre-existing insomnia, sleep apnea or RSL


other: quality-of-life assessment

other: questionnaire administration

behavioral: management of therapy complications

behavioral: cognitive assessment

behavioral: educational intervention

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Oxana Palesh

New Trial Alerts